Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples